Detalhe da pesquisa
1.
Targeting Cell Cycle Facilitates E1A-Independent Adenoviral Replication.
J Virol
; 97(6): e0037023, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37219458
2.
Concepts in Oncolytic Adenovirus Therapy.
Int J Mol Sci
; 22(19)2021 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638863
3.
STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy.
Int J Mol Sci
; 21(3)2020 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32046095
4.
Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy.
BJU Int
; 119(1): 30-37, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27037533
5.
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.
Semin Cancer Biol
; 35 Suppl: S25-S54, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25892662
6.
A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer.
Prostate
; 76(13): 1160-8, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27198487
7.
CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1.
J Urol
; 195(3): 771-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26318986
8.
Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.
Eur J Nucl Med Mol Imaging
; 43(12): 2105-2113, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27317482
9.
A robust blood gene expression-based prognostic model for castration-resistant prostate cancer.
BMC Med
; 13: 201, 2015 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26297150
10.
Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients.
BMC Cancer
; 15: 458, 2015 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26051431
11.
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 41(4): 694-701, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24297503
12.
Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches.
Int J Cancer
; 133(9): 2145-56, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23625723
13.
Genome-Wide CRISPR Screening for the Identification of Therapy Resistance-Associated Genes in Urothelial Carcinoma.
Methods Mol Biol
; 2684: 155-165, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410233
14.
Identification of the KIF and MCM protein families as novel targets for combination therapy with CDK4/6 inhibitors in bladder cancer.
Urol Oncol
; 41(5): 253.e11-253.e20, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813612
15.
25 years International Bladder Cancer Network (IBCN): The past, the present, and the future.
Urol Oncol
; 41(7): 302-306, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36437158
16.
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1.
Urol Oncol
; 41(7): 307-312, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702704
17.
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.
Clin Cancer Res
; 29(10): 1996-2011, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892582
18.
Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer.
BJU Int
; 110(11 Pt B): E635-40, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22889368
19.
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus.
Nat Commun
; 13(1): 4689, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948546
20.
Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer.
J Pers Med
; 11(5)2021 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33923231